Xuzhou Medical University, china
Dr. Rui Wang is a consultant oncologist, and a physician-scientist in Suqian Affiliated Hospital of Xuzhou Medical University and Cancer Science Institute of Singapore. She has more than 11 years of clinic working experience with tumor patients. She holds an M.D and has research interest in cancer chromosome instability and immunology. Her research has been focused on tumor genome instability and how innate immune signalling and metabolic pathways orchestrate with overall aim of identifying innovative therapeutic targets.
Rui Wang has gained international research experience working at esteemed institutions in Yale University School of Medicine and Cancer Science Institute of Singapore, has a distinguished publication record as the first/corresponding author on highly impacted journals like Cell Reports, Critical Reviews in Oncology/Hematology, Steroids, International Journal of Oncology, featuring research articles, reviews, and conference contributions.
National Lebanese and Beirut Arab Universities, Lebanon
Dr. Ibrahim, MD, FRCP, is a Professor of Hematology/Oncology at the National Lebanese and Beirut Arab Universities, and a Clinical Associate at the Department of Internal Medicine, American University of Beirut (Lebanon). He is also Associate Dean for research at Balamand University, Faculty of Medicine and Medical Sciences (Lebanon).
Dr. Ibrahim obtained his MD in 1987 and pursued a fellowship in Clinical and Biological Hematology, followed by a post-fellowship training in Hematopoietic Stem Cell Transplantation at the University of Paris, then, at the Fred Hutchinson Cancer Center in Seattle under the supervision of Professor E. D. Thomas (Nobel Prize of Medicine). He was also trained in Immunology at the laboratory of Professor Jean Dausset (Nobel Prize of Medicine) at the University of Paris.
Later, he was appointed Assistant, then Associate Professor/ Attending Physician at the Department of Hematology and Bone Marrow Transplantation Unit at Institute Gustave Roussy, University of Paris (XI) Saclay.
In 1997, Dr. Ibrahim established the first comprehensive Hematology and Bone Marrow Transplantation Program at Makassed University Hospital - Beirut, via a Franco-Lebanese cooperation with the Institute Gustave Roussy. Currently, he serves as Chairman of the Department of Internal Medicine and Director of the Bone Marrow Transplant and Cellular Therapy Program at the Middle East Institute of Health (University of Balamand - Lebanon), as well as the Chairman of the Hematology/Oncology Department and Director of the Bone Marrow Transplant and Cellular Therapy Program at Makassed University Hospital (Beirut Arab University - Lebanon).
Dr. Ibrahim coordinated phase I and II studies in the Department of Oncology at the Institute Gustave Roussy and has participated in several international and national research programs and studies in the field of Hematology/Oncology and Cellular Therapy. He was a Research Associate at the CNRS (Centre National de la Recherche Scientifique)-UA1156 at the Institute Gustave Roussy and has been a Research Associate at Lebanese CNRS. He has been an Associate Director of Research for PhD at the Faculty of Pharmacy-University of Paris V.
Dr. Ibrahim has taken teaching responsibility in several sections of the Master of Human Biology and the Diploma of Oncology at the University of Paris (XI) Saclay. He also was a co-Director of a joint fellowship in Heamtology organized between Makassed University Hospital and the Faculty of Medicine at the University of Lille II (France).
In 1993, he was elected as a core member of the EORTC-Leukemias Group. He is a member of the Board of Directors of the Eastern Mediterranean Group for Blood and Marrow Transplantation (EMBMT). He is also a member of the American Society of Hematology (ASH), European Hematology Association (EHA), European Society for Blood and Marrow Transplantation (EBMT), and Eurasian Hematology – Oncology Group (EHOG).
His main interests are Hematological Malignancies and Cellular Therapy (particularly Hematopoietic Stem Cell Transplantation). He is on the Editorial Boards and acts as an active reviewer for multiple journals in the field.
Dr. Ibrahim has authored and co-authored more than 400 medical publications and book chapters.
Aristotle University of Thessaloniki, Greece
Dr. Ioannidis is currently an Assistant Professor of Surgery in the Medical School of Aristotle University of Thessaloniki. He studied medicine in the Aristotle University of Thessaloniki and graduated at 2005. He received his MSC in “Medical Research Methodology” in 2008 from Aristotle University of Thessaloniki and in “Surgery of Liver, Biliary Tree and Pancreas” from the Democritus University of Thrace in 2016. He received his PhD degree in 2014 from the Aristotle University of Thessaloniki as valedictorian for his thesis “The effect of combined administration of omega-3 and omega-6 fatty acids in ulcerative colitis. Experimental study in rats.” He is a General Surgeon with special interest in laparoscopic surgery and surgical oncology and also in surgical infections, acute care surgery, nutrition and ERAS and vascular access. He has received fellowships for EAES, ESSO, EPC, ESCP and ACS and has published more than 180 articles with more than 3000 citations and an H-index of 28
At Tecnym, we are committed to protecting your privacy and ensuring the security of your personal information. This Privacy Policy outlines how we collect, use, disclose, and safeguard your personal data when you interact with our services, including our website, mobile applications, and any other platforms we provide (collectively referred to as the "Services"). Please read this policy carefully to understand our practices regarding your personal information.
Personal Information:
We may collect certain personal information from you when you interact with our Services. This may include but is not limited to your name, email address, phone number, postal address, payment details, and any other information you provide us voluntarily.
Cookies and Tracking Technologies:
We may use cookies, web beacons, and similar tracking technologies to collect information about your usage of our Services. This helps us improve our Services and enhance your experience. You can manage your cookie preferences through your browser settings.
We may use the information we collect from you for various purposes, including but not limited to:
We may share your personal information with certain third parties in the following circumstances,
Service Providers: We may engage trusted third-party service providers to assist us in delivering our Services. These providers have access to your information solely to perform the services on our behalf.
Business Transfers: If we are involved in a merger, acquisition, or sale of all or a portion of our assets, your personal information may be transferred as part of that transaction.
Legal Requirements: We may disclose your information to comply with applicable laws, regulations, legal processes, or government requests.
Data Security: We employ reasonable security measures to protect your personal information from unauthorized access, disclosure, alteration, and destruction. However, no method of transmission over the Internet or electronic storage is 100% secure, and we cannot guarantee absolute security.
Your Choices: You have the right to access, update, correct, or delete your personal information held by us. You can do so by contacting us using the information provided below.
Children's Privacy: Our Services are not intended for individuals under the age of 18. We do not knowingly collect personal information from children without appropriate parental consent. If you believe we have collected personal information from a child, please contact us immediately, and we will take appropriate steps to remove that information.
We may update this Privacy Policy periodically to reflect changes in our practices or legal requirements. We will notify you of any material changes by posting the updated policy on our website or through other appropriate means. Your continued use of our Services after the effective date of the revised Privacy Policy constitutes your acceptance of the updated terms.
